![ADDING MULTIMEDIA Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder) | Business Wire ADDING MULTIMEDIA Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder) | Business Wire](https://mms.businesswire.com/media/20181221005620/en/697202/4/INBRIJA+Blister+Pack+and+Capsules.jpg)
ADDING MULTIMEDIA Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder) | Business Wire
![Inbrija, inhaled levodopa for Parkinson's off periods, arrives in Spain | Quick-acting therapy for when motor symptoms return |Parkinson's News Today Inbrija, inhaled levodopa for Parkinson's off periods, arrives in Spain | Quick-acting therapy for when motor symptoms return |Parkinson's News Today](https://parkinsonsnewstoday.com/wp-content/uploads/2023/03/UpdateBell.png)
Inbrija, inhaled levodopa for Parkinson's off periods, arrives in Spain | Quick-acting therapy for when motor symptoms return |Parkinson's News Today
![Pharmacy_talk on Twitter: "🔵 #FDA has approved Inbrija (levodopa inhalation powder) for intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa #Parkinson https://t.co/YwdPCcQV0j" / Twitter Pharmacy_talk on Twitter: "🔵 #FDA has approved Inbrija (levodopa inhalation powder) for intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa #Parkinson https://t.co/YwdPCcQV0j" / Twitter](https://pbs.twimg.com/media/Dx0_opTWkAEX6UG.jpg:large)